$1.01 Billion is the total value of Rhenman & Partners Asset Management AB's 89 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 14.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LLY | Sell | LILLY ELI & CO | $35,367,000 | -25.0% | 123,500 | -27.4% | 3.49% | +11.3% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $35,333,000 | -23.2% | 335,837 | -21.0% | 3.49% | +13.9% |
| ABBV | Sell | ABBVIE INC | $31,611,000 | -30.6% | 195,000 | -41.8% | 3.12% | +3.0% |
| UNH | Sell | UNITED HEALTH GROUP INC | $29,578,000 | -51.1% | 58,000 | -51.7% | 2.92% | -27.5% |
| MCK | Sell | MCKESSON CORP | $29,082,000 | -34.0% | 95,000 | -46.3% | 2.87% | -2.0% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $28,328,000 | -23.8% | 181,976 | -37.2% | 2.80% | +13.0% |
| PFE | Sell | PFIZER INC | $27,050,000 | -53.7% | 522,500 | -47.8% | 2.67% | -31.3% |
| CI | Sell | CIGNA CORP NEW | $26,836,000 | -16.9% | 112,000 | -20.0% | 2.65% | +23.3% |
| CVS | Sell | CVS HEALTH CORP | $23,784,000 | -44.0% | 235,000 | -42.7% | 2.35% | -17.0% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $23,357,000 | -36.4% | 89,500 | -45.8% | 2.30% | -5.6% |
| ANTM | Sell | ANTHEM INC | $22,694,000 | -50.4% | 46,199 | -52.9% | 2.24% | -26.4% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $22,588,000 | -42.3% | 510,000 | -44.0% | 2.23% | -14.3% |
| ABMD | Buy | ABIOMED INC | $22,524,000 | +19.6% | 68,000 | +30.8% | 2.22% | +77.5% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $21,228,000 | -29.1% | 130,000 | -25.7% | 2.09% | +5.2% |
| JNJ | Sell | JOHNSON & JOHNSON | $20,027,000 | -54.1% | 113,000 | -55.3% | 1.98% | -31.8% |
| REGN | New | REGENERON PHARMACEUTICALS | $19,905,000 | – | 28,500 | +100.0% | 1.96% | – |
| COO | Sell | COOPER COS INC | $19,209,000 | -16.5% | 46,000 | -15.2% | 1.90% | +23.9% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $19,155,000 | -7.1% | 377,000 | -12.3% | 1.89% | +37.9% |
| MRK | Sell | MERCK & CO. INC | $18,461,000 | -20.2% | 225,000 | -25.0% | 1.82% | +18.3% |
| MDT | Sell | MEDTRONIC PLC | $17,752,000 | -42.6% | 160,000 | -45.9% | 1.75% | -14.8% |
| THC | Sell | TENET HEALTHCARE CORP | $17,450,000 | +1.4% | 203,000 | -3.3% | 1.72% | +50.5% |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $17,133,000 | -15.7% | 280,000 | -28.2% | 1.69% | +25.0% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $16,962,000 | -28.1% | 220,000 | -17.0% | 1.67% | +6.6% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $16,709,000 | -42.7% | 108,000 | -50.5% | 1.65% | -15.0% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $16,126,000 | -22.3% | 136,000 | -9.3% | 1.59% | +15.4% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $15,838,000 | +9.0% | 52,500 | +31.2% | 1.56% | +61.8% |
| CNC | Sell | CENTENE CORP DEL | $15,744,000 | -26.5% | 187,000 | -26.7% | 1.55% | +9.1% |
| AXNX | Sell | AXONICS INC | $15,024,000 | -15.2% | 240,000 | -23.8% | 1.48% | +25.8% |
| BNTX | New | BIONTECH SEsponsored ads | $14,498,000 | – | 85,000 | +100.0% | 1.43% | – |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $14,028,000 | -52.1% | 23,750 | -46.0% | 1.38% | -28.9% |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $13,080,000 | +31.7% | 30,000 | +100.0% | 1.29% | +95.5% |
| HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $13,050,000 | +37.0% | 268,244 | +21.9% | 1.29% | +103.2% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $12,317,000 | -44.6% | 149,800 | -0.1% | 1.22% | -17.8% |
| INSP | Buy | INSPIRE MED SYS INC | $12,193,000 | +14.2% | 47,500 | +2.4% | 1.20% | +69.4% |
| BDX | Sell | BECTON DICKINSON & CO | $11,837,000 | -48.6% | 44,500 | -51.1% | 1.17% | -23.8% |
| HUM | Sell | HUMANA INC | $11,532,000 | -55.0% | 26,500 | -51.8% | 1.14% | -33.3% |
| SWAV | Buy | SHOCKWAVE MEDICAL INC | $11,363,000 | +86.0% | 54,800 | +61.2% | 1.12% | +176.1% |
| CYTK | Buy | CYTOKINETICS INC | $10,859,000 | +58.8% | 295,000 | +96.7% | 1.07% | +135.4% |
| ABT | Sell | ABBOTT LABS | $10,652,000 | -24.5% | 90,000 | -10.0% | 1.05% | +12.0% |
| PRVA | Sell | PRIVIA HEALTH GROUP INC | $10,625,000 | -30.9% | 397,510 | -31.5% | 1.05% | +2.5% |
| GILD | Sell | GILEAD SCIENCES INC | $10,107,000 | -49.9% | 170,000 | -38.2% | 1.00% | -25.7% |
| DHR | Sell | DANAHER CORPORATION | $9,973,000 | -15.7% | 34,000 | -5.6% | 0.98% | +25.2% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $9,844,000 | -23.0% | 105,000 | -30.5% | 0.97% | +14.2% |
| XNCR | Sell | XENCOR INC | $9,168,000 | -50.0% | 343,636 | -23.6% | 0.90% | -25.8% |
| SGEN | Sell | SEAGEN INC | $8,787,000 | -56.0% | 61,000 | -52.0% | 0.87% | -34.7% |
| VEEV | Sell | VEEVA SYS INC | $8,073,000 | -48.3% | 38,000 | -36.7% | 0.80% | -23.2% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $7,909,000 | -32.1% | 475,000 | -20.8% | 0.78% | +0.6% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $7,652,000 | -41.4% | 65,000 | -35.0% | 0.76% | -13.1% |
| RCM | Sell | R1 RCM INC | $7,551,000 | -45.5% | 282,189 | -48.7% | 0.74% | -19.2% |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $7,379,000 | -30.8% | 680,676 | -9.2% | 0.73% | +2.7% |
| MGTX | Buy | MEIRAGTX HLDGS PLC | $6,925,000 | -33.8% | 500,000 | +11.1% | 0.68% | -1.7% |
| IMGN | Sell | IMMUNOGEN INC | $6,783,000 | -39.3% | 1,425,000 | -5.0% | 0.67% | -10.0% |
| TDOC | Sell | TELADOC HEALTH INC | $6,636,000 | -43.7% | 92,000 | -26.4% | 0.66% | -16.5% |
| GH | Sell | GUARDANT HEALTH INC | $6,293,000 | -68.6% | 95,000 | -52.5% | 0.62% | -53.4% |
| SILK | Sell | SILK RD MED INC | $6,194,000 | -28.5% | 150,000 | -25.0% | 0.61% | +6.1% |
| GKOS | Sell | GLAUKOS CORP | $6,088,000 | -24.1% | 105,291 | -39.8% | 0.60% | +12.8% |
| NVCR | Sell | NOVOCURE LTD | $5,775,000 | -39.9% | 69,700 | -42.1% | 0.57% | -10.8% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $5,362,000 | -0.3% | 589,200 | -21.4% | 0.53% | +47.8% |
| EXAS | Sell | EXACT SCIENCES CORP | $5,314,000 | -38.0% | 76,000 | -30.9% | 0.52% | -8.1% |
| PGNY | Sell | PROGYNY INC | $5,140,000 | -1.0% | 100,000 | -1.2% | 0.51% | +47.0% |
| IMCR | Buy | IMMUNOCORE HLDGS PLCads | $5,097,000 | +66.1% | 170,472 | +89.4% | 0.50% | +146.6% |
| ALKS | Sell | ALKERMES PLC | $4,736,000 | -3.4% | 180,000 | -14.3% | 0.47% | +43.3% |
| HCAT | Sell | HEALTH CATALYST INC | $4,703,000 | -51.7% | 180,000 | -25.0% | 0.46% | -28.3% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $4,555,000 | -8.2% | 981,582 | -1.8% | 0.45% | +36.1% |
| GDRX | New | GOODRX HLDGS INC | $4,543,000 | – | 235,000 | +100.0% | 0.45% | – |
| SGMO | Sell | SANGAMO THERAPEUTICS INC | $4,424,000 | -26.0% | 761,429 | -0.5% | 0.44% | +9.8% |
| ISEE | Sell | IVERIC BIO INC | $4,376,000 | -23.9% | 260,000 | -25.7% | 0.43% | +12.8% |
| ONEM | Sell | 1LIFE HEALTHCARE INC | $4,158,000 | -54.8% | 375,250 | -29.2% | 0.41% | -33.0% |
| OSH | Sell | OAK STR HEALTH INC | $4,032,000 | -47.7% | 150,000 | -31.8% | 0.40% | -22.4% |
| RVNC | New | REVANCE THERAPEUTICS INC | $3,868,000 | – | 198,358 | +100.0% | 0.38% | – |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $3,821,000 | -6.2% | 1,277,770 | -15.9% | 0.38% | +39.1% |
| NTLA | New | INTELLIA THERAPEUTICS INC | $3,634,000 | – | 50,000 | +100.0% | 0.36% | – |
| ACCD | Sell | ACCOLADE INC | $3,512,000 | -36.3% | 200,000 | -4.8% | 0.35% | -5.4% |
| MYOV | Sell | MYOVANT SCIENCES LTD | $3,321,000 | -17.3% | 249,300 | -0.3% | 0.33% | +22.8% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $3,309,000 | -75.1% | 613,884 | -35.4% | 0.33% | -63.1% |
| PHAT | Buy | PHATHOM PHARMACEUTICALS INC | $3,201,000 | -11.7% | 235,210 | +26.3% | 0.32% | +31.1% |
| BIIB | Sell | BIOGEN INC | $3,159,000 | -88.6% | 15,000 | -87.0% | 0.31% | -83.0% |
| PHR | Sell | PHREESIA INC | $3,084,000 | -41.1% | 117,000 | -5.2% | 0.30% | -12.6% |
| STXS | Sell | STEREOTAXIS INC | $2,974,000 | -40.2% | 797,330 | -0.3% | 0.29% | -11.5% |
| VRAY | Sell | VIEWRAY INC | $2,881,000 | -30.1% | 735,000 | -5.2% | 0.28% | +3.6% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $2,630,000 | +14.8% | 71,000 | -5.3% | 0.26% | +70.4% |
| EPIX | Sell | ESSA PHARMA INC | $2,540,000 | -57.1% | 410,923 | -2.2% | 0.25% | -36.3% |
| MGNX | Sell | MACROGENICS INC | $2,529,000 | -48.3% | 287,081 | -4.5% | 0.25% | -23.1% |
| OLK | OLINK HLDG ABsponsored ads | $2,472,000 | -5.6% | 140,000 | 0.0% | 0.24% | +40.2% | |
| GTHX | Sell | G1 THERAPEUTICS INC | $2,403,000 | -29.3% | 316,137 | -2.7% | 0.24% | +4.9% |
| OLMA | OLEMA PHARMACEUTICALS INC | $2,130,000 | -54.7% | 500,000 | 0.0% | 0.21% | -32.9% | |
| Buy | RAPID MICRO BIOSYSTEMS INC | $2,037,000 | -2.7% | 300,000 | +53.0% | 0.20% | +44.6% | |
| PIRS | PIERIS PHARMACEUTICALS INC | $909,000 | -23.1% | 300,000 | 0.0% | 0.09% | +13.9% | |
| ANNX | ANNEXON INC | $683,000 | -76.5% | 250,000 | 0.0% | 0.07% | -65.3% | |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS INC | $0 | – | -60,000 | -100.0% | -0.04% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -265,000 | -100.0% | -0.05% | – |
| INNV | Exit | INNOVAGE HLDG CORP | $0 | – | -150,000 | -100.0% | -0.05% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -200,000 | -100.0% | -0.19% | – |
| VCRA | Exit | VOCERA COMMUNICATIONS INC | $0 | – | -60,000 | -100.0% | -0.26% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -115,000 | -100.0% | -0.33% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -90,000 | -100.0% | -0.77% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -59,000 | -100.0% | -1.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.